Report on the quality of life analysis from the phase III trial of pion versus photon radiotherapy in locally advanced prostate cancer. (Q53524448)

15 May 2018

title

Report on the quality of life analysis from the phase III trial of pion versus photon radiotherapy in locally advanced prostate cancer. (English)

1 reference

15 May 2018

Adaptive radiation therapy

main subject

0 references

phase III clinical trial

0 references

1 reference

Duncan GG

1

1 reference

15 May 2018

Philips N

series ordinal

2

1 reference

15 May 2018

Pickles T

series ordinal

3

1 reference

15 May 2018

publication date

1 April 2000

1 reference

15 May 2018

European Journal of Cancer

published in

1 reference

15 May 2018

volume

36

1 reference

15 May 2018

issue

6

1 reference

15 May 2018

page(s)

759-765

1 reference

15 May 2018

Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer: results of a randomized prospective trial

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Neutron radiation and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

The Possibility of Therapeutic Applications of Beams of Negative π-Mesons

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

The response of mouse tumours to fractionated doses of pions: determination of therapeutic gain factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

The response of murine b-16 melanoma to fractionated doses of pions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Pions--the potential for therapeutic gain in locally advanced prostate cancer: dose escalation and toxicity studies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Pion conformal radiation of prostate cancer: results of a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Pion radiation for high grade astrocytoma: results of a randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

RTOG's first quality of life study—RTOG 90-20: A phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Assessment of endpoints for clinical trials for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Comparison of perspectives on prostate cancer: analyses of survey data.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

A method for assessing the quality of life of cancer patients: replication of the factor structure

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

High-dose intravenous pamidronate for metastatic bone pain

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Concurrent validity of the modified Edmonton Symptom Assessment System with the Rotterdam Symptom Checklist and the Brief Pain Inventory

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Patient acceptability and practical implications of pharmacokinetic studies in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Adjuvant psychological therapy for patients with cancer: a prospective randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Assessment of validity and clinical application of an Italian version of the Rotterdam Symptom Checklist

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Doxorubicin in advanced breast cancer: influence of schedule on response, survival and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Longitudinal data analysis (repeated measures) in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Quality-of-life outcomes in men treated for localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Late effects of radiation therapy for prostate carcinoma: the patient's perspective of bladder, bowel and sexual morbidity.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Patient self-assessment of complications and quality of life after conformal neutron and photon irradiation for localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Influence of urological morbidity on quality of life in patients with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Self-assessed sexual function after pelvic irradiation for prostate carcinoma. Comparison with an age-matched control group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

The preservation of potency after external beam irradiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

10.1016/S0959-8049(99)00341-X

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018